Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study Article

Kuo, Dennis Yi-Shin, Blank, Stephanie V, Christos, Paul J et al. (2010). Paclitaxel plus oxaliplatin for recurrent or metastatic cervical cancer: A New York Cancer Consortium Study . GYNECOLOGIC ONCOLOGY, 116(3), 442-446. 10.1016/j.ygyno.2009.10.082

Open Access

cited authors

  • Kuo, Dennis Yi-Shin; Blank, Stephanie V; Christos, Paul J; Kim, Mimi; Caputo, Thomas A; Pothuri, Bhavana; Hershman, Dawn; Goldman, Noah; Ivy, Percy S; Runowicz, Carolyn D; Muggia, Franco; Goldberg, Gary L; Einstein, Mark H

sustainable development goals

publication date

  • March 1, 2010

published in

keywords

  • CARCINOMA
  • CELL LUNG-CANCER
  • CHEMOTHERAPY
  • CISPLATIN
  • GYNECOLOGIC-ONCOLOGY-GROUP
  • Life Sciences & Biomedicine
  • Obstetrics & Gynecology
  • Oncology
  • Oxaliplatin
  • PHASE-II
  • PLATINUM
  • Paclitaxel
  • Recurrent cervical cancel
  • Response
  • Science & Technology
  • Toxicity

Location

  • San Antonio, TX

Digital Object Identifier (DOI)

publisher

  • ACADEMIC PRESS INC ELSEVIER SCIENCE

start page

  • 442

end page

  • 446

volume

  • 116

issue

  • 3